PharmX Technologies (ASX:PHX) Interest Expense : A$-0.04 Mil (TTM As of Dec. 2023)

View and export this data going back to 1973. Start your Free Trial

What is PharmX Technologies Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. PharmX Technologies's interest expense for the six months ended in Dec. 2023 was A$ -0.03 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.04 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. PharmX Technologies's Operating Income for the six months ended in Dec. 2023 was A$ 0.34 Mil. PharmX Technologies's Interest Expense for the six months ended in Dec. 2023 was A$ -0.03 Mil. PharmX Technologies's Interest Coverage for the quarter that ended in Dec. 2023 was 11.43. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

PharmX Technologies Interest Expense Historical Data

The historical data trend for PharmX Technologies's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmX Technologies Interest Expense Chart

PharmX Technologies Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Interest Expense

Get a 7-Day Free Trial

-0.05

-0.14

-0.07

-0.05

PharmX Technologies Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial															-0.04	-0.03	-0.05	-0.01	-0.03

PharmX Technologies Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.04 Mil.

PharmX Technologies (ASX:PHX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

PharmX Technologies's Interest Expense for the six months ended in Dec. 2023 was A$-0.03 Mil. Its Operating Income for the six months ended in Dec. 2023 was A$0.34 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was A$0.19 Mil.

PharmX Technologies's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	0.343	/	-0.03
	=	11.43

The higher the ratio, the stronger the company's financial strength is.

PharmX Technologies (ASX:PHX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PharmX Technologies Ltd (ASX:PHX) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Castlereagh Street, Level 11, Sydney, NSW, AUS, 2000

Website

https://www.corumgroup.com.au

PharmX Technologies Ltd Formerly Corum Group Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business. the company discontinued the e-commerce business in 2022.